Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function
Latest Information Update: 10 Jul 2026
At a glance
- Drugs VC 005 (Primary)
- Indications Ankylosing spondylitis; Atopic dermatitis; Rheumatoid arthritis; Vitiligo
- Focus Pharmacokinetics
- Sponsors Jiangsu Vcare Pharmatech
Most Recent Events
- 07 Jul 2026 Status changed from not yet recruiting to recruiting.
- 04 May 2026 New trial record